Researchers have found in a recent study that weight loss and lowering blood sugar levels lower significantly the all-cause ...

A study published in Diabetes, Obesity and Metabolism has revealed that individuals with type 2 diabetes face significantly ...

The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss—up to 24% with ...

People exposed to higher levels of air pollution may be more likely to develop meningioma, a typically noncancerous brain ...

Mumbai: Wockhardt has announced a significant strategic realignment of its U.S. business, marking an exit from the generic ...

A new study published in the journal of Arthritis Care and Research revelaed that metabolic syndrome is associated with ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

A large-scale cohort study led by researchers from Tianjin University, Shenyang Medical College, Shengjing Hospital of China ...

In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...

Portugal: Researchers have found in a cross-sectional study from Portugal that pseudoexfoliation (PEX) syndrome is linked to ...

AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), have ...

Berlin: Bayer has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA, regulatory authority ...